Discontinuation of Immunosuppressive Therapy in Patients With Neuromyelitis Optica Spectrum Disorder With Aquaporin-4 Antibodies
Citation Manager Formats
Make Comment
See Comments
See original article:

In the article “Discontinuation of Immunosuppressive Therapy in Patients With Neuromyelitis Optica Spectrum Disorder With Aquaporin-4 Antibodies” by S.-H. Kim et al,1 Su-Hyun Kim's contributions listed in the appendix should be “Drafting/revision of the manuscript for content, major role in the acquisition of data, study concept or design, and analysis or interpretation of data.” The publisher regrets the error.
- © 2021 American Academy of Neurology
Reference
- 1.↵
- Kim S-H,
- Jang H,
- Park NY, et al.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. David E. Vaillancourt and Dr. Shannon Y. Chiu
► Watch
Related Articles
Alert Me
Recommended articles
-
Article
Discontinuation of Immunosuppressive Therapy in Patients With Neuromyelitis Optica Spectrum Disorder With Aquaporin-4 AntibodiesSu-Hyun Kim, Hyunmin Jang, Na Young Park et al.Neurology: Neuroimmunology & Neuroinflammation, February 23, 2021 -
Articles
AQP4 antibody–positive Thai casesClinical features and diagnostic problemsS. Siritho, I. Nakashima, T. Takahashi et al.Neurology, August 03, 2011 -
Research Article
CNS Demyelinating Attacks Requiring Ventilatory Support With Myelin Oligodendrocyte Glycoprotein or Aquaporin-4 AntibodiesHannah H. Zhao-Fleming, Cristina Valencia Sanchez, Elia Sechi et al.Neurology, August 13, 2021 -
Article
Pregnancy in Patients With AQP4-Ab, MOG-Ab, or Double-Negative Neuromyelitis Optica DisorderNicolas Collongues, Cecilia Alves Do Rego, Bertrand Bourre et al.Neurology, February 24, 2021